Mach7 Technologies Ltd
ASX:M7T
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.32
0.8
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Mach7 Technologies Ltd
Mach7 Technologies Ltd
Cost of Revenue
Mach7 Technologies Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mach7 Technologies Ltd
ASX:M7T
|
Cost of Revenue
-AU$1.4m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
Cost of Revenue
-AU$236.7k
|
CAGR 3-Years
-37%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
Cost of Revenue
-$19.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-13%
|
|
|
Pro Medicus Ltd
ASX:PME
|
Cost of Revenue
-AU$301k
|
CAGR 3-Years
15%
|
CAGR 5-Years
27%
|
CAGR 10-Years
0%
|
|
|
Medibio Ltd
ASX:MEB
|
Cost of Revenue
-AU$160
|
CAGR 3-Years
91%
|
CAGR 5-Years
71%
|
CAGR 10-Years
N/A
|
|
|
Medadvisor Ltd
ASX:MDR
|
Cost of Revenue
-AU$47.9m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-116%
|
CAGR 10-Years
N/A
|
|
Mach7 Technologies Ltd
Glance View
Mach7 Technologies Ltd. provides medical imaging software and services for healthcare institutions. The company is headquartered in Melbourne, Victoria and currently employs 90 full-time employees. The company went IPO on 2005-11-30. The principal activities of the Company include the provision of enterprise imaging data sharing, storage and interoperability for healthcare enterprises globally. The firm operates through two segments: sale of software and rendering of professional services. The sale of software segment engaged in selling software licenses. The provision of the software license is a distinct performance obligation as the customer can derive substantial benefits from the license on its own when the license is delivered and installed. Healthcare enterprises globally segment engaged in providing professional services, such as implementation, training and annual support services. The firm provides various solutions, including Enterprise Diagnostic Viewing, Enterprise Data Management and Enterprise PACS.
See Also
What is Mach7 Technologies Ltd's Cost of Revenue?
Cost of Revenue
-1.4m
AUD
Based on the financial report for Jun 30, 2024, Mach7 Technologies Ltd's Cost of Revenue amounts to -1.4m AUD.
What is Mach7 Technologies Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
2%
Over the last year, the Cost of Revenue growth was -46%. The average annual Cost of Revenue growth rates for Mach7 Technologies Ltd have been -35% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
